Crustacean antimicrobial peptides

Details Crustacean antimicrobial peptides Crustacean antimicrobial peptides

2000-04-12

2003-11-04

Low, Christopher S. F. (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S300000, C435S069100, C435S252800, C435S254100, C435S320100, C435S325000, C536S023100

Reexamination Certificate

active

06642203

ABSTRACT:

This application is a 371 of PCT/FR98/01583, filed Jul. 20, 1998.
The invention relates to new antimicrobial peptides produced by penaeid prawns.
Peptides endowed with antimicrobial properties are produced by a wide variety of (animal or plant) species in which they participitate in nonspecific mechanisms of defence against infections. These peptides are the subject of increasing interest, in particular because they generally possess a broad activity spectrum and a low cytotoxicity for eukaryotic cells.
Comparisons of the amino acid sequences, of the secondary structures and the functional similarities have made it possible to define four main groups to which most of the antimicrobial peptides described up until now can be attached. For a review, cf. for example HOFFMANN et al., in Phylogenetic Perspectives in Immunity; The Insect Host Defense. Chapter 4, pp. 43-65 (1994):
1. A first group comprises linear peptides consisting essentially of basic and hydrophobic amino acids; the cecropins of insects and of mammals, and the magainins of the skin of batrachians, in particular are classified in this group;
2. A second group comprises peptides comprising intramolecular disulphide bridges; the defensins of insects or of mammals, the brevinins of the skin of batraciens, the thanatin of insects, which exhibits a strong sequence homology with the brevinins [FEHLBAUM et al. Proc. Natl. Acad. Sci. USA. 93, pp. 1221-1225, (1996)], the tachyplesins, produced by primitive marine arthropods, as well as various peptides obtained from the haemolymph of scorpions [EHRET-SABATIER et al., J. Biol. Chem., 271, 47, pp. 29537-29544, (1996)], in particular are classified in this group;
3. The third group comprises the peptides rich in proline, among which there may be classified the apidaecins and the abaecins of hymenopterans, drosocin and pyrrhocoricin, also produced by insects, and the bactenecins of mammals. The only antimicrobial peptide produced by a decapod crustacean which had been characterized up until now also belongs to this class: it is an antibacterial peptide rich in proline, similar to bactenecin-7, and obtained from the haemocytes of the crab
Carcinus maenas
[SCHNAPP et al., Eur. J. Biochem. 240, pp. 532-539 (1996)];
4. The fourth class comprises peptides or polypeptides rich in glycine, such as attacins, sarcotoxins and diptericins, all isolated from insects.
The inventors have now purified and characterized new antimicrobial peptides from the haemolymph of penaeid prawns, and have also obtained DNA sequences encoding these peptides.
The subject of the present invention is these antimicrobial peptides, called hereinafter penaeidins, which possess the following characteristics:
their molecular mass is about 5 to 7 kDa;
their pHi is greater than or equal to 9;
their N-terminal sequence comprises a region (A) of about 15 to 25 amino acids, rich in proline, (at least ⅛ and preferably between ⅛ and ⅓ of the amino acids of this region are prolines);
their C-terminal portion comprises a region (B) of about 20 to 30 amino acids, which contains 6 cysteine residues forming three intramolecular disulphide bridges.
According to a preferred embodiment of the present invention, region (A) comprises the following sequence (I):
Pro Xaa
1
ProXaa
2
ProXaa
3
Pro(I, SEQ ID NO: 15 or 19)
in which Pro represents a proline, Xaa
1
, represents a nonpolar neutral amino acid, Xaa
2
represents a basic amino acid, Xaa
3
represents a proline or a peptide bond.
According to a preferred feature of this embodiment, region (A) comprises the following sequence (II):
ProXaa
1
ProXaa
2
ProXaa
3
ProXaa
1
Xaa
1
Xaa
2
ProXaa
4
Xaa
4
(II, SEQ ID NO: 17 or 21)
in which Pro, Xaa
1
, Xaa
2
and Xaa
3
are as defined above, and Xaa4 represents a nonpolar neutral amino acid or a proline.
Advantageously, region (A) comprises the following sequence (III):
ProXaa
1
ProXaa
2
ProXaa
3
ProXaa
1
Xaa
1
Xaa
2
ProXaa
1
Pro Xaa
1
Xaa
1
ProXaa
1
Xaa
1
Pro(III, SEQ ID NO: 18 or 22)
in which Pro, Xaa
1
, Xaa
2
and Xaa
3
are as defined above.
According to another preferred embodiment of the present invention, the 6 cysteine residues of region (B) are arranged according to the following sequence (IV):
Cys S
1
Cys S
2
Cys Cys S
3
Cys Cys (IV, SEQ ID NO: 16 or 20)
in which Cys represents a cysteine, S
1
represents an amino acid or a peptide sequence of 2 or 3 amino acids, S
2
represents a peptide sequence of 10 amino acids, S
3
represents a peptide sequence of 5 amino acids.
The present invention also encompasses peptides comprising or consisting of fragments of at least 5 amino acids of a penaeidin as defined above, and in particular peptides comprising or consisting of region (A) and/or region (B), as well as peptides comprising or consisting of sequences (I), (II), (III) and/or (IV).
According to a preferred embodiment of a peptide in accordance with the invention, its N-terminal end is blocked by a pyroglutamic acid residue, and/or its C-terminal end is amidated.
By way of illustration of the subject of the present invention, the characteristics of 3 penaeidins isolated from the haemolymph of the prawn
Penaeus vannamei
, called hereinafter penaeidin 1, penaeidin 2 and penaeidin 3, are more specifically indicated below.
“The sequences of these 3 peptides (1-letter code) are represented in
FIGS. 1
a
(penaeidin 1, SEQ ID NO: 5),
1
b
(penaeidin 2, SEQ ID NO: 6 with amidated C-terminus) and
1
c
(penaeidin 3, SEQ ID NO: 7 with amidated C-terminus and pyroglutamic acid at the N-terminus); the alignment of the 3 sequences is represented in
FIG. 1
d
: the conserved sequences are delimited.
FIG. 2
represents a cDNA sequence of penaeidin 2 and the corresponding peptide sequence (3-letter code);
FIG. 3A
represents a cDNA sequence of penaeidin 3 and the corresponding peptide sequence (3-letter code);
FIG. 3B
represents the peptide sequence (1-letter code) of other isoforms of penaeidin 3 (P3-b and P3-c, SEQ ID NOS: 23 and 24, respectively): the sequence variations are delimited.”
The cDNA sequences of penaeidin 2 and of penaeidin 3 are respectively represented in the sequence listing in the annex under the numbers SEQ ID NO: 1 and SEQ ID NO:3, and the sequences of their products of translation are respectively represented in the sequence listing in the annex under the numbers SEQ ID NO: 2 and SEQ ID NO: 4.
The peptide sequences of the mature forms of penaeidins 1, 2 and 3 are respectively represented in the sequence listing in the annex under the numbers SEQ ID NO: 5, SEQ ID NO: 6 and SEQ ID NO: 7.
These penaeidins exhibit no significant homology with the antimicrobial peptides known in the prior art, and define a new group of antimicrobial peptides.
Penaeidins 1 and 2 comprise 50 amino acids, and have a molecular mass of about 5.5 kDa; penaeidin 3 comprises 62 amino acids and its molecular mass is about 6.6 kDa.
They are cationic peptides possessing a net positive charge of 7 for penaeidins 1 and 2, and of 8 for penaeidin 3; their calculated isoelectric points vary from 9.34 for penaeidins 1 and 2, to 9.84 for penaeidin 3.
The 3 peptides have an N-terminal domain rich in proline, and a C-terminal domain comprising 6 cysteine residues forming three intramolecular disulphide bridges, and where the 4 cysteine residues closest to the C-terminal end are organized into 2 doublets separated by 5 residues.
The most central cysteines are respectively separated by 1, 2, or 3 residues in penaeidins 1, 2 and 3.
The N-terminal end of penaeidin 3 is blocked by a pyroglutamic acid residue. Blocking by similar residues has already been observed in other antimicrobial peptides.
The C-terminal end of penaeidins 2 and 3 is amidated. Such a C-terminal amidation has already been observed for certain antimicrobial peptides of other marine invertebrates (Limulus tachyplesins), as well as for the cecropins of insects and the magainins of amphibians. Such a modification reinforces the stability of the molecule, and it appears that it increases the antimicrobial activity.
Penaei

Affiliated with

Also associated with

Rating

Crustacean antimicrobial peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crustacean antimicrobial peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crustacean antimicrobial peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3172370